Hematology/Oncology Fellowship Program
Fellows alphabetically by year
1st year ~ (2009-10, 2010-11, 2011-12)
- GILCREASE, Weldon
- HUERTER, Luke
- POLAVARAM, Latha
- THOMAS, Justin
2nd year ~ (2008-09, 2009-10, 2010-2011)
- COHEN, Adam
- DONEGAN, Shaun
- MANNING, Jared
- RUDRAPATNA, Venkatesh
3rd year ~ (2007-08, 2008-09, 2009-2010)
Director: Martha Glenn, MD Associate Professor of Medicine
Associate Program Director: Theresa Werner, MD
Fellowship Program Coordinator: MaryAnn Griffiths
Satisfactory completion of an accredited program in internal medicine is a requirement for entry into this subspecialty training program. Subspecialty training in Hematology-Oncology is a voluntary component of education in Internal Medicine. The Hematology-Oncology training program is offered as a two-year Oncology, two-year Hematology or three-year combined fellowship. Certification in the subspecialties of Hematology and/or Oncology is offered by the American Board of Internal Medicine upon successful completion of the certification examination given by the Board. Specific requirements for certification can be viewed on the ABIM web site (www.abim.org). Fellows desiring clinical training for private practice will complete the two-year program with certification (board eligibility) in either Hematology or Oncology. Those fellows with interests in academic medicine with a major focus on research are eligible for the three-year program with certification possible in both specialties. Acceptance into the three-year program is contingent on satisfactory performance during the first year, identification by the fellow of a faculty mentor, research project for the second and third year, and career development plan. Fellows will be required to write a short proposal of what they intend to achieve during the second and third year. This plan requires approval by the Fellowship Committee. For fellows whose salaries will be funded by either the Hematology or Oncology training grants, approval by the committee administering the grant will also be necessary.
General Program Description
The University of Utah is a major teaching and research institution. The Department of Medicine uses as its primary training site the Huntsman Cancer Institute (HCI) at the University of Utah and the University of Utah Health Sciences Center. The George E. Wahlen Department of Veterans Affairs Medical Center (VAMC) and Primary Children’s Medical Center (PCMC) are also used as a part of most of the training programs, including the Hematology-Oncology subspecialty program. Major clinical care and clinical and basic research programs are a part of all specialty programs including internal medicine and hematology-oncology. The Hematology-Oncology Division staffs at the HCI, University Health Sciences and VAMC are full-time academic faculty members in the University of Utah Department of Medicine. Rotations at LDS Hospital and PCMC use faculty from those institutions, most of whom are also University faculty. As part of the University of Utah, HCI is the primary location for the Hematology-Oncology fellowship training program. It also serves as the primary location for outpatient Hematology-Oncology clinic rotations for residents from the School of Medicine, notably those from the Internal Medicine training program.
Clinical Component
The Hematology-Oncology training program includes a maximum of 12 Fellows who interact on a daily basis with faculty, with each other, and with the general and subspecialty residents from internal medicine and other specialty training programs. The program consists of structured educational activities including in-and-outpatient experiences, consultative rotations, technical training, conferences, didactic lectures, teaching experiences, assigned readings, review sessions, and research training (clinical & basic science). All of these are designed with specific goals, implementation methods, and evaluations so that the Fellow can acquire all of the knowledge, cognitive, technical, interpersonal, humanistic, professional and judgment skills necessary to be an academic or practicing Hematologist-Oncologist as well as a responsible and contributing part of the medical community and society. Each of the specific educational components is detailed below.
Research Component
A broad range of research resources and opportunities are available in the division, the department, and the institution. This encompasses both clinical and basic science research.
General Features of Training in Hematology/Oncology
Subspecialty training in Hematology-Oncology at the University of Utah provides advanced training to allow the hematology-oncology fellow to acquire consultative expertise. All major dimensions of the curriculum are structured educational experiences with specified goals and objectives, a defined methodology for teaching/learning, and an explicit method for evaluation. The curriculum assures that trainees will have the opportunity to achieve the cognitive knowledge, psychomotor skills, interpersonal skills, professional attitudes, and practical experience required of a sub-specialist in hematology, oncology, or both. In addition, fellows will be expected to maintain in-depth knowledge of general internal medicine, as hematologist-oncologists are often called upon to provide primary care to patients. The program at the University of Utah emphasizes scholarship, self-instruction, development of critical analysis of clinical problems, and the ability to make appropriate decisions. The program provides appropriate opportunity for the trainee to acquire skills in the performance of the techniques required for the practice of the subspecialty. Appropriate supervision by faculty is provided during all educational experiences.
More information regarding the Hematology/Oncology Fellowship program can be found here. |
